Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group, Susanna Naggie
doi: https://doi.org/10.1101/2022.07.12.22277548

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted July 13, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group, Susanna Naggie
medRxiv 2022.07.12.22277548; doi: https://doi.org/10.1101/2022.07.12.22277548
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area